Effect of voriconazole on a corneal abscess caused by fusarium

被引:20
作者
Polizzi, A [1 ]
Siniscalchi, C [1 ]
Mastromarino, A [1 ]
Saccà, SC [1 ]
机构
[1] Univ Genoa, Dept Neurol & Visual Sci, Sect Ophthalmol, Genoa, Italy
来源
ACTA OPHTHALMOLOGICA SCANDINAVICA | 2004年 / 82卷 / 06期
关键词
voriconazole; Fusarium solani; keratomycosis; corneal abscess therapy;
D O I
10.1111/j.1600-0420.2004.00366.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To describe a case of corneal abscess caused by Fusurium solani that did not respond to common antifungal agents. Method: Case report. Results: Twenty days after accidental contact with vegetation, a 56-year-old man presented with a corneal abscess. Corneal ulceration developed and a perforating keratoplasty was performed. After a microbiological examination, the diagnosis of F. solani infection was made. Systemic and topical amphotericin B and fluconazole were prescribed, with no results. A new abscess formed on the transplanted graft and a wound leak developed. We administered topical and systemic voriconazole. No side-effects were observed. The choroidal detachment and the surgical transplant recovered completely in 20 days. A vascular leukoma developed at the site of the transplanted corneal abscess. Conclusion: From a functional point of view, another corneal transplant will be necessary. Voriconazole was effective in treating a severe keratomycosis caused by F. solani that was resistant to other topical and systemic antifungal agents.
引用
收藏
页码:762 / 764
页数:3
相关论文
共 11 条
[1]   CLINICAL TYPES OF CORNEAL TRANSPLANT REJECTION - THEIR MANIFESTATIONS, FREQUENCY, PREOPERATIVE CORRELATES, AND TREATMENT [J].
ALLDREDGE, OC ;
KRACHMER, JH .
ARCHIVES OF OPHTHALMOLOGY, 1981, 99 (04) :599-604
[2]   In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature [J].
Espinel-Ingroff, A ;
Boyle, K ;
Sheehan, DJ .
MYCOPATHOLOGIA, 2001, 150 (03) :101-115
[3]   Treatment of postkeratitis fusarium endophthalmitis with amphotericin B lipid complex [J].
Goldblum, D ;
Frueh, BE ;
Zimmerli, S ;
Böhnke, M .
CORNEA, 2000, 19 (06) :853-856
[4]  
Hoffman HL, 2002, EXPERT OPIN INV DRUG, V11, P409
[5]   PHARMACOLOGIC MANAGEMENT OF KERATOMYCOSES [J].
JOHNS, KJ ;
ODAY, DM .
SURVEY OF OPHTHALMOLOGY, 1988, 33 (03) :178-188
[6]  
Marco F, 1998, MED MYCOL, V36, P433
[7]   CYTOLOGIC STUDY OF HERPETIC KERATITIS - PREPARATION OF CORNEAL SCRAPINGS [J].
PLOTKIN, J ;
REYNAUD, A ;
OKUMOTO, M .
ARCHIVES OF OPHTHALMOLOGY, 1971, 85 (05) :597-&
[8]   Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole [J].
Reis, A ;
Sundmacher, R ;
Tintelnot, K ;
Agostini, H ;
Jensen, HE ;
Althaus, C .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (08) :932-933
[9]  
ROSA RH, 1994, OPHTHALMOLOGY, V101, P1005
[10]   New targets and delivery systems for antifungal therapy [J].
Walsh, TJ ;
Viviani, MA ;
Arathoon, E ;
Chiou, C ;
Ghannoum, M ;
Groll, AH ;
Odds, FC .
MEDICAL MYCOLOGY, 2000, 38 :335-347